Skip to main content
. 2019 Dec 2;20:442. doi: 10.1186/s12882-019-1637-y

Fig. 3.

Fig. 3

Proposed decision-making algorithm of medication in primary MN patients with ACS. MN: membranous nephropathy; ACS: acute coronary syndrome; STEMI: ST-elevation myocardial infarction; NSTE: non ST-elevation; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; PCI: percutaneous coronary intervention; AC: anticoagulation; UFH: unfractionated heparin; LRB: low risk of bleeding; HRB: high risk of bleeding; h: hours; LDL-C: low-density lipoprotein cholesterol